CCR5 and infection: Δ32/Δ32 homozygotes remain resistant to infection with CCR5 tropic variants of HIV, while among heterozygous Δ32/wild-type (wt) subjects beneficial, AIDS protective effects, have been noted in the early years of infection [5], [6].